ArticleWorld journal of clinical oncology2012

Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicin.

Tal Grenader et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.